China Resources Double-Crane Pharmaceutical Co.,Ltd. (SHSE:600062) agreed to acquire an 89.681% stake in Guizhou Tianan Pharmaceutical Company from Jiangxi Boya Pharmaceutical Investment Co., Ltd and China Resources Boya Bio-pharmaceutical Group Co.,Ltd (SZSE:300294) for CNY 260 million on September 26, 2023. China Resources Double-Crane Pharmaceutical Co.,Ltd. entered into an agreement to acquire an 89.681% stake in Guizhou Tianan Pharmaceutical Company from Jiangxi Boya Pharmaceutical Investment Co., Ltd and China Resources Boya Bio-pharmaceutical Group Co.,Ltd on September 27, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
31.28 CNY | -0.29% | -1.14% | -7.13% |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
31.28 CNY | -0.29% | -1.14% | 2.18B | ||
21.2 CNY | -0.84% | +0.66% | 2.99B | ||
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-7.13% | 2.18B | |
-4.66% | 86.13B | |
+1.32% | 39.82B | |
-19.27% | 30.42B | |
+57.86% | 25.23B | |
-16.09% | 15.35B | |
-9.14% | 11.95B | |
-17.69% | 11.6B | |
-43.00% | 11.51B | |
+5.24% | 8.71B |
- Stock Market
- Equities
- 300294 Stock
- News China Resources Boya Bio-pharmaceutical Group Co.,Ltd
- China Resources Double-Crane Pharmaceutical Co.,Ltd. agreed to acquire an 89.681% stake in Guizhou Tianan Pharmaceutical Company from Jiangxi Boya Pharmaceutical Investment Co., Ltd and China Resources Boya Bio-pharmaceutical Group Co.,Ltd for CNY 260 million